Table of Contents

June 2012, Volume 19, Number 3

Editorial

    • Anne M Deschamps and
    • Charis Eng

    Engaging basic scientists in translational research

    Endocr Relat Cancer 19 (3) E1-E3, doi:10.1530/ERC-12-0106 first published on 18 April 2012

Profile

    • Elaine A Ostrander

    Missteps and mistakes, friends and heroes

    Endocr Relat Cancer 19 (3) P5-P8, doi:10.1530/ERC-12-0027

Review

    • Claudia Lanari,
    • Victoria Wargon,
    • Paola Rojas,
    • and Alfredo A Molinolo

    Antiprogestins in breast cancer treatment: are we ready?

    Endocr Relat Cancer 19 (3) R35-R50, doi:10.1530/ERC-11-0378 first published on 20 February 2012
    • Fábio Pereira,
    • María Jesús Larriba,
    • and Alberto Muñoz

    Vitamin D and colon cancer

    Endocr Relat Cancer 19 (3) R51-R71, doi:10.1530/ERC-11-0388 first published on 1 March 2012
    • Anna Karpathakis,
    • Martyn Caplin,
    • and Christina Thirlwell

    Hitting the target: where do molecularly targeted therapies fit in the treatment scheduling of neuroendocrine tumours?

    Endocr Relat Cancer 19 (3) R73-R92, doi:10.1530/ERC-12-0050 first published on 3 April 2012
    • Leonardo Oliveira Reis

    Variations of serum testosterone levels in prostate cancer patients under LH-releasing hormone therapy: an open question

    Endocr Relat Cancer 19 (3) R93-R98, doi:10.1530/ERC-12-0040 first published on 7 March 2012

Article

    • Philipp Mayer,
    • Andreas Harjung,
    • Marco Breinig,
    • Lars Fischer,
    • Volker Ehemann,
    • Mona Malz,
    • Hans Scherübl,
    • Sarah Britsch,
    • Jens Werner,
    • Michael A Kern,
    • Hendrik Bläker,
    • Peter Schirmacher,
    • and Frank Bergmann

    Expression and therapeutic relevance of heat-shock protein 90 in pancreatic endocrine tumors

    Endocr Relat Cancer 19 (3) 217-232, doi:10.1530/ERC-11-0227 first published on 22 December 2011
    • Maria A Tichomirowa,
    • Misu Lee,
    • Anne Barlier,
    • Adrian F Daly,
    • Ilaria Marinoni,
    • Marie-Lise Jaffrain-Rea,
    • Luciana A Naves,
    • Patrice Rodien,
    • Vincent Rohmer,
    • Fabio Rueda Faucz,
    • Philippe Caron,
    • Bruno Estour,
    • Pierre Lecomte,
    • Françoise Borson-Chazot,
    • Alfred Penfornis,
    • Maria Yaneva,
    • Mirtha Guitelman,
    • Emily Castermans,
    • Catherine Verhaege,
    • Jean-Louis Wémeau,
    • Antoine Tabarin,
    • Carmen Fajardo Montañana,
    • Brigitte Delemer,
    • Veronique Kerlan,
    • Jean-Louis Sadoul,
    • Christine Cortet Rudelli,
    • Françoise Archambeaud,
    • Sabine Zacharieva,
    • Marily Theodoropoulou,
    • Thierry Brue,
    • Alain Enjalbert,
    • Vincent Bours,
    • Natalia S Pellegata,
    • and Albert Beckers

    Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds

    Endocr Relat Cancer 19 (3) 233-241, doi:10.1530/ERC-11-0362 first published on 30 January 2012
    • Serk In Park and
    • Laurie K McCauley

    Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells

    Endocr Relat Cancer 19 (3) 243-254, doi:10.1530/ERC-11-0278 first published on 30 January 2012
    • Paraskevi Xekouki,
    • Michael M Hatch,
    • Lin Lin,
    • De Alexandre Rodrigo,
    • Monalisa Azevedo,
    • Maria de la Luz Sierra,
    • Isaac Levy,
    • Emmanouil Saloustros,
    • Andreas Moraitis,
    • Anelia Horvath,
    • E Kebebew,
    • Dax A Hoffman,
    • and Constantine A Stratakis

    KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome

    Endocr Relat Cancer 19 (3) 255-260, doi:10.1530/ERC-12-0022 first published on 9 February 2012
    • E Rapizzi,
    • T Ercolino,
    • L Canu,
    • V Giaché,
    • M Francalanci,
    • C Pratesi,
    • A Valeri,
    • and M Mannelli

    Mitochondrial function and content in pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers

    Endocr Relat Cancer 19 (3) 261-269, doi:10.1530/ERC-11-0263 first published on 9 February 2012
    • Viktoria Evdokimova,
    • Manoj Gandhi,
    • Jayanagendra Rayapureddi,
    • James R Stringer,
    • and Yuri E Nikiforov

    Formation of carcinogenic chromosomal rearrangements in human thyroid cells after induction of double-strand DNA breaks by restriction endonucleases

    Endocr Relat Cancer 19 (3) 271-281, doi:10.1530/ERC-11-0314 first published on 9 February 2012
    • Angelica Malinoc,
    • Maren Sullivan,
    • Thorsten Wiech,
    • Kurt Werner Schmid,
    • Cordula Jilg,
    • Joern Straeter,
    • Serdar Deger,
    • Michael M Hoffmann,
    • Alexander Bosse,
    • Gerd Rasp,
    • Charis Eng,
    • and Hartmut P H Neumann

    Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3

    Endocr Relat Cancer 19 (3) 283-290, doi:10.1530/ERC-11-0324 first published on 20 February 2012
    • Yu-Yu Liu,
    • Xiaoli Zhang,
    • Matthew D Ringel,
    • and Sissy M Jhiang

    Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells

    Endocr Relat Cancer 19 (3) 291-304, doi:10.1530/ERC-11-0288 first published on 21 February 2012
    • Su Jung Oh,
    • Holger H H Erb,
    • Alfred Hobisch,
    • Frédéric R Santer,
    • and Zoran Culig

    Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways

    Endocr Relat Cancer 19 (3) 305-319, doi:10.1530/ERC-11-0298 first published on 1 March 2012
    OPEN ACCESS ARTICLE
    • Hongbing Chen,
    • Yin Sun,
    • Chengyu Wu,
    • Clara E Magyar,
    • Xinmin Li,
    • Liang Cheng,
    • Jorge L Yao,
    • Steven Shen,
    • Adeboye O Osunkoya,
    • Chaozhao Liang,
    • and Jiaoti Huang

    Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway

    Endocr Relat Cancer 19 (3) 321-331, doi:10.1530/ERC-11-0368 first published on 2 March 2012
    • Briseis Aschebrook-Kilfoy,
    • Gila Neta,
    • Alina V Brenner,
    • Amy Hutchinson,
    • Ruth M Pfeiffer,
    • Erich M Sturgis,
    • Li Xu,
    • William Wheeler,
    • Michele M Doody,
    • Stephen J Chanock,
    • and Alice J Sigurdson

    Common genetic variants in metabolism and detoxification pathways and the risk of papillary thyroid cancer.

    Endocr Relat Cancer 19 (3) 333-344, doi:10.1530/ERC-11-0372 first published on 2 March 2012
    • Giorgio Grani,
    • Angela Nesca,
    • Marianna Del Sordo,
    • Anna Calvanese,
    • Giovanni Carbotta,
    • Marta Bianchini,
    • and Angela Fumarola

    Interpretation of serum calcitonin in patients with chronic autoimmune thyroiditis

    Endocr Relat Cancer 19 (3) 345-349, doi:10.1530/ERC-12-0013 first published on 7 March 2012
    • Maria Cristina De Martino,
    • Peter M van Koetsveld,
    • Richard A Feelders,
    • Diana Sprij-Mooij,
    • Marlijn Waaijers,
    • Steven W J Lamberts,
    • Wouter W de Herder,
    • Annamaria Colao,
    • Rosario Pivonello,
    • and Leo J Hofland

    The role of mTOR inhibitors in the inhibition of growth and cortisol secretion in human adrenocortical carcinoma cells

    Endocr Relat Cancer 19 (3) 351-364, doi:10.1530/ERC-11-0270 first published on 14 March 2012
    • Guy Wayne Novotny,
    • Kirstine C Belling,
    • Jesper Bertram Bramsen,
    • John E Nielsen,
    • Jette Bork-Jensen,
    • Kristian Almstrup,
    • Si Brask Sonne,
    • Jørgen Kjems,
    • Ewa Rajpert-De Meyts,
    • and Henrik Leffers

    MicroRNA expression profiling of carcinoma in situ cells of the testis

    Endocr Relat Cancer 19 (3) 365-379, doi:10.1530/ERC-11-0271 first published on 14 March 2012
    • Sunil Amin,
    • Richard R P Warner,
    • Steven H Itzkowitz,
    • and Michelle Kang Kim

    The risk of metachronous cancers in patients with small-intestinal carcinoid tumors: a US population-based study

    Endocr Relat Cancer 19 (3) 381-387, doi:10.1530/ERC-11-0392 first published on 27 March 2012
    • Luqman Sulaiman,
    • Inga-Lena Nilsson,
    • C Christofer Juhlin,
    • Felix Haglund,
    • Anders Höög,
    • Catharina Larsson,
    • and Jamileh Hashemi

    Genetic characterization of large parathyroid adenomas

    Endocr Relat Cancer 19 (3) 389-407, doi:10.1530/ERC-11-0140 first published on 27 March 2012
    OPEN ACCESS ARTICLE
    • Katrin-Janine Heiliger,
    • Julia Hess,
    • Donata Vitagliano,
    • Paolo Salerno,
    • Herbert Braselmann,
    • Giuliana Salvatore,
    • Clara Ugolini,
    • Isolde Summerer,
    • Tatjana Bogdanova,
    • Kristian Unger,
    • Gerry Thomas,
    • Massimo Santoro,
    • and Horst Zitzelsberger

    Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice

    Endocr Relat Cancer 19 (3) 409-421, doi:10.1530/ERC-11-0387 first published on 27 March 2012
    • Kathrin Zitzmann,
    • George Vlotides,
    • Stephan Brand,
    • Harald Lahm,
    • Gerald Spöttl,
    • Burkhard Göke,
    • and Christoph J Auernhammer

    Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms

    Endocr Relat Cancer 19 (3) 423-434, doi:10.1530/ERC-12-0074 first published on 12 April 2012
    • Daphne R Pringle,
    • Zhirong Yin,
    • Audrey A Lee,
    • Parmeet K Manchanda,
    • Lianbo Yu,
    • Alfred F Parlow,
    • David Jarjoura,
    • Krista M D La Perle,
    • and Lawrence S Kirschner

    Thyroid-specific ablation of the Carney complex gene, PRKAR1A, results in hyperthyroidism and follicular thyroid cancer

    Endocr Relat Cancer 19 (3) 435-446, doi:10.1530/ERC-11-0306 first published on 18 April 2012
    • Joanna Klubo-Gwiezdzinska,
    • Kirk Jensen,
    • John Costello,
    • Aneeta Patel,
    • Victoria Hoperia,
    • Andrew Bauer,
    • Kenneth D Burman,
    • Leonard Wartofsky,
    • and Vasyl Vasko

    Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells

    Endocr Relat Cancer 19 (3) 447-456, doi:10.1530/ERC-12-0046 first published on 2 March 2012

Letter to the Editor

    • Luciana Pinto Brito,
    • Tamaya Castro Ribeiro,
    • Madson Q Almeida,
    • Alexander Augusto de Lima Jorge,
    • Iberê Cauduro Soares,
    • Ana Claudia Latronico,
    • Berenice Bilharinho Mendonca,
    • Maria Candida Barisson Villares Fragoso,
    • and Antonio Marcondes Lerario

    The role of fibroblast growth factor receptor 4 overexpression and gene amplification as prognostic markers in pediatric and adult adrenocortical tumors

    Endocr Relat Cancer 19 (3) L11-L13, doi:10.1530/ERC-11-0231 first published on 12 January 2012
    • Angelique Huijbers,
    • Theo S Plantinga,
    • Leo A B Joosten,
    • Katja K H Aben,
    • Julius Gudmundsson,
    • Martin den Heijer,
    • Lambertus A L M Kiemeney,
    • Mihai G Netea,
    • Ad R M M Hermus,
    • and Romana T Netea-Maier

    The effect of the ATG16L1 Thr300Ala polymorphism on susceptibility and outcome of patients with epithelial cell-derived thyroid carcinoma

    Endocr Relat Cancer 19 (3) L15-L18, doi:10.1530/ERC-11-0302 first published on 1 February 2012
    • Lucia Gagliardi,
    • King-Hwa Ling,
    • Chung H Kok,
    • Joseph Carolan,
    • Peter Brautigan,
    • Rosalie Kenyon,
    • Richard J D'Andrea,
    • Mark Van der Hoek,
    • Christopher N Hahn,
    • David J Torpy,
    • and Hamish S Scott

    Genome-wide gene expression profiling identifies overlap with malignant adrenocortical tumours and novel mechanisms of inefficient steroidogenesis in familial ACTH-independent macronodular adrenal hyperplasia

    Endocr Relat Cancer 19 (3) L19-L23, doi:10.1530/ERC-11-0210 first published on 1 March 2012
    • Leandro Kasuki,
    • Leonardo Vieira Neto,
    • Luiz Eduardo A Wildemberg,
    • Leandro Machado Colli,
    • Margaret de Castro,
    • Christina M Takiya,
    • and Mônica R Gadelha

    AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression

    Endocr Relat Cancer 19 (3) L25-L29, doi:10.1530/ERC-12-0020 first published on 14 March 2012
    • Lucas Leite Cunha,
    • Elaine Cristina Morari,
    • Ana Carolina Trindade Guihen,
    • Daniela Razolli,
    • Renê Gerhard,
    • Suely Nonogaki,
    • Fernando Augusto Soares,
    • José Vassallo,
    • and Laura Sterian Ward

    Infiltration of a mixture of different immune cells may be related to molecular profile of differentiated thyroid cancer

    Endocr Relat Cancer 19 (3) L31-L36, doi:10.1530/ERC-11-0285 first published on 28 March 2012
|

This Issue

June 2012; 19 (3)
  1. Editorial
  2. Profile
  3. Review
  4. Article
  5. Letter to the Editor

Find articles in this issue containing these words:

New Articles: issue in progress

  1. July 2018, 25 (7)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most